[6-[(5-methyl-2-phenyl-4-thiazolyl)methoxy]-pyridin-3-yl]methanol | 441357-25-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: [6-[(5-methyl-2-phenyl-4-thiazolyl)methoxy]-pyridin-3-yl]methanol
• 英文别名: 6-(5-methyl-2-phenyl-4-thiazolylmethoxy)-3-pyridylmethanol；[6-[(5-methyl-2-phenyl-1,3-thiazol-4-yl)methoxy]pyridin-3-yl]methanol
• CAS: 441357-25-1
• 化学式: C₁₇H₁₆N₂O₂S
• 分子量: 312.392
• InChiKey: RBWCAAOJPUVIDF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  22
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  83.5
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  [6-[(5-methyl-2-phenyl-4-thiazolyl)methoxy]-pyridin-3-yl]methanol 在 氯化亚砜 作用下， 反应 1.0h， 以92%的产率得到5-chloromethyl-2-(5-methyl-2-phenyl-4-thiazolylmethoxy)pyridine
  参考文献：
  名称：

  EP1394154

  摘要：

  公开号：
• 作为产物：
  描述：

  6-[(5-methyl-2-phenyl-4-thiazolyl)methoxy]nicotinaldehyde 在 sodium tetrahydroborate 作用下， 以 四氢呋喃 、 乙醇 为溶剂， 反应 0.5h， 以97%的产率得到[6-[(5-methyl-2-phenyl-4-thiazolyl)methoxy]-pyridin-3-yl]methanol
  参考文献：
  名称：

  ALKANOIC ACID DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND USE THEREOF

  摘要：

  公开号：

  EP1357115B1

文献信息

• Five-membered heterocyclic alkanoic acid derivative
  申请人：——

  公开号：US20040063775A1

  公开（公告）日：2004-04-01

  The present invention relates to a compound represented by the formula 1 wherein R 1 is an optionally substituted 5-membered heterocyclic group; X is a bond etc.; Q is a divalent hydrocarbon group having 1 to 20 carbon atoms; Y is a bond etc.; ring A is an aromatic ring optionally further having 1 to 3 substituents; Z is —(CH 2 ) n —Z 1 — (n is an integer of 0 to 8 and Z 1 is a bond etc.) and the like; ring B is a 5-membered heterocycle optionally further having 1 to 3 substituents; W is a divalent saturated hydrocarbon group having 1 to 20 carbon atoms; R 2 is —OH etc., or a salt thereof. A pharmaceutical composition containing this compound is useful as a prophylactic or therapeutic agent of diseases such as diabetes mellitus and the like.

  本发明涉及一种由式1表示的化合物，其中R1是可选择取代的5元杂环基团; X是一个键等; Q是具有1到20个碳原子的双价碳氢基团; Y是一个键等; 环A是一个芳香环，可选择进一步具有1到3个取代基; Z是—(CH2)n—Z1—(n为0到8的整数，Z1是一个键等)等; 环B是一个可选择进一步具有1到3个取代基的5元杂环; W是具有1到20个碳原子的双价饱和碳氢基团; R2是—OH等，或其盐。包含该化合物的制药组合物可用作糖尿病等疾病的预防或治疗剂。
• Alkanoic acid derivatives process for their production and use thereof
  申请人：——

  公开号：US20040058965A1

  公开（公告）日：2004-03-25

  An alkanoic acid derivative useful as a prophylactic or therapeutic agent of diabetes mellitus, hyperlipidemia, impaired glucose tolerance and the like can be provided by a compound represented by the formula 1 wherein R 1 is an optionally substituted 5-membered aromatic heterocyclic group; X is a bond and the like; Q is a divalent hydrocarbon group having 1 to 20 carbon atoms; Y is a bond and the like, ring A is an aromatic ring optionally further having 1 to 3 substituents; Z is —(CH 2 ) n —Z 1 — (n is an integer of 1 to 8 and Z 1 is an oxygen atom and the like) and the like; ring B is a pyridine ring optionally further having 1 to 3 substituents, and the like; U is a bond and the like; W is a divalent hydrocarbon group having 1 to 20 carbon atoms; and R 3 is —OH and the like, provided that, when ring B is a benzene ring optionally further having 1 to 3 substituents, U should be a bond, or a salt thereof.

  一种可以用作糖尿病、高脂血症、糖耐量受损等预防或治疗剂的脂肪酸衍生物可以由以下式1所表示的化合物提供，其中R1是可选取代的5-成员芳香杂环基；X是键等；Q是具有1到20个碳原子的二价碳氢基团；Y是键等；环A是一种芳香环，可选择进一步具有1到3个取代基；Z是—（CH2）n—Z1—（n是1到8的整数，Z1是氧原子等）等；环B是吡啶环，可选择进一步具有1到3个取代基等；U是键等；W是具有1到20个碳原子的二价碳氢基团；R3是—OH等；但是，当环B是苯环，可选择进一步具有1到3个取代基时，U应为键，或其盐。
• FIVE-MEMBERED HETEROCYCLIC ALKANOIC ACID DERIVATIVE
  申请人：Takeda Chemical Industries, Ltd.

  公开号：EP1394154A1

  公开（公告）日：2004-03-03

  The present invention relates to a compound represented by the formula wherein R1 is an optionally substituted 5-membered heterocyclic group; X is a bond etc.; Q is a divalent hydrocarbon group having 1 to 20 carbon atoms; Y is a bond etc.; ring A is an aromatic ring optionally further having 1 to 3 substituents; Z is -(CH2)n-Z1- (n is an integer of 0 to 8 and Z1 is a bond etc.) and the like; ring B is a 5-membered heterocycle optionally further having 1 to 3 substituents; W is a divalent saturated hydrocarbon group having 1 to 20 carbon atoms; R2 is -OH etc., or a salt thereof. A pharmaceutical composition containing this compound is useful as a prophylactic or therapeutic agent of diseases such as diabetes mellitus and the like.

  本发明涉及一种由式表示的化合物 其中 R1 是任选取代的 5 元杂环基团；X 是键等；Q 是具有 1 至 20 个碳原子的二价烃基；Y 是键等；环 A 是芳香环，可任选进一步具有 1 至 3 个取代基；Z 是-(CH2)n-Z1-（n 是 0 至 8 的整数，Z1 是键等）等；环 B 是 5 元杂环，可任选进一步具有 1 至 3 个取代基；W 是二价饱和杂环，可任选进一步具有 1 至 3 个取代基。环 B 是五元杂环，可选进一步具有 1 至 3 个取代基；W 是具有 1 至 20 个碳原子的二价饱和烃基；R2 是-OH 等、或其盐。含有该化合物的药物组合物可作为糖尿病等疾病的预防或治疗药物。
• US7241785B2
  申请人：——

  公开号：US7241785B2

  公开（公告）日：2007-07-10
• US7238716B2
  申请人：——

  公开号：US7238716B2

  公开（公告）日：2007-07-03